Mair Churchill
Concepts (413)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA | 39 | 2023 | 1418 | 2.920 |
Why?
| | Histones | 14 | 2023 | 670 | 2.240 |
Why?
| | High Mobility Group Proteins | 17 | 2012 | 45 | 2.050 |
Why?
| | DNA-Binding Proteins | 21 | 2019 | 1467 | 1.760 |
Why?
| | Mitochondrial Proteins | 6 | 2019 | 263 | 1.540 |
Why?
| | Bacterial Proteins | 17 | 2018 | 976 | 1.450 |
Why?
| | Transcription Factors | 14 | 2019 | 1728 | 1.330 |
Why?
| | Molecular Chaperones | 9 | 2023 | 200 | 1.220 |
Why?
| | DNA, Mitochondrial | 4 | 2019 | 212 | 1.190 |
Why?
| | Chromatin Assembly Factor-1 | 3 | 2023 | 12 | 1.140 |
Why?
| | Acyl-Butyrolactones | 5 | 2014 | 10 | 1.130 |
Why?
| | Cell Cycle Proteins | 8 | 2014 | 629 | 1.100 |
Why?
| | Molecular Sequence Data | 42 | 2016 | 2835 | 1.070 |
Why?
| | Ligases | 7 | 2011 | 38 | 1.060 |
Why?
| | Histone Chaperones | 3 | 2012 | 15 | 1.040 |
Why?
| | Models, Molecular | 31 | 2015 | 1571 | 1.020 |
Why?
| | Nucleosomes | 7 | 2018 | 168 | 0.940 |
Why?
| | Chromatin Assembly and Disassembly | 3 | 2018 | 109 | 0.940 |
Why?
| | Amino Acid Sequence | 34 | 2016 | 2088 | 0.920 |
Why?
| | Repressor Proteins | 5 | 2018 | 428 | 0.820 |
Why?
| | Quorum Sensing | 7 | 2018 | 80 | 0.810 |
Why?
| | Protein Binding | 24 | 2019 | 2239 | 0.800 |
Why?
| | DNA Damage | 3 | 2023 | 437 | 0.760 |
Why?
| | Saccharomyces cerevisiae Proteins | 6 | 2012 | 411 | 0.700 |
Why?
| | 4-Butyrolactone | 7 | 2012 | 23 | 0.680 |
Why?
| | Binding Sites | 24 | 2014 | 1306 | 0.660 |
Why?
| | Pseudomonas aeruginosa | 6 | 2018 | 392 | 0.640 |
Why?
| | Cytosine | 2 | 2019 | 49 | 0.590 |
Why?
| | Protein Structure, Tertiary | 14 | 2012 | 834 | 0.560 |
Why?
| | Nucleic Acid Conformation | 18 | 2015 | 723 | 0.560 |
Why?
| | CpG Islands | 1 | 2019 | 175 | 0.550 |
Why?
| | Protein Multimerization | 6 | 2019 | 201 | 0.530 |
Why?
| | Base Sequence | 23 | 2012 | 2119 | 0.490 |
Why?
| | Crystallography, X-Ray | 11 | 2015 | 477 | 0.480 |
Why?
| | Transcription, Genetic | 5 | 2019 | 1429 | 0.470 |
Why?
| | Signal Transduction | 9 | 2018 | 5234 | 0.450 |
Why?
| | Drosophila Proteins | 5 | 2014 | 207 | 0.440 |
Why?
| | Sequence Alignment | 9 | 2015 | 360 | 0.420 |
Why?
| | DNA Methylation | 2 | 2019 | 721 | 0.420 |
Why?
| | Promoter Regions, Genetic | 5 | 2019 | 1236 | 0.420 |
Why?
| | Receptors, Progesterone | 4 | 2011 | 241 | 0.420 |
Why?
| | Gram-Negative Bacteria | 3 | 2010 | 80 | 0.410 |
Why?
| | Mutation, Missense | 4 | 2017 | 331 | 0.410 |
Why?
| | Drosophila melanogaster | 11 | 2010 | 237 | 0.390 |
Why?
| | Protein Conformation | 12 | 2015 | 914 | 0.390 |
Why?
| | Chromatin | 5 | 2018 | 557 | 0.390 |
Why?
| | Lipase | 1 | 2013 | 76 | 0.370 |
Why?
| | Site-Specific DNA-Methyltransferase (Adenine-Specific) | 2 | 2003 | 2 | 0.360 |
Why?
| | Mitochondria | 1 | 2019 | 996 | 0.350 |
Why?
| | Trans-Activators | 6 | 2018 | 371 | 0.350 |
Why?
| | Insect Proteins | 4 | 2000 | 38 | 0.350 |
Why?
| | Saccharomyces cerevisiae | 3 | 2012 | 584 | 0.330 |
Why?
| | Sequence Homology, Amino Acid | 9 | 2012 | 382 | 0.330 |
Why?
| | Animals | 45 | 2022 | 38030 | 0.300 |
Why?
| | Crystallization | 7 | 2011 | 131 | 0.300 |
Why?
| | Transcriptional Activation | 2 | 2011 | 368 | 0.300 |
Why?
| | Protein Structure, Secondary | 9 | 2011 | 357 | 0.250 |
Why?
| | Mutation | 12 | 2016 | 4082 | 0.240 |
Why?
| | Gene Expression Regulation, Bacterial | 6 | 2014 | 337 | 0.240 |
Why?
| | Transferases | 1 | 2006 | 27 | 0.240 |
Why?
| | HMG-Box Domains | 3 | 2015 | 3 | 0.240 |
Why?
| | Recombination, Genetic | 3 | 2003 | 202 | 0.240 |
Why?
| | Substrate Specificity | 6 | 2022 | 387 | 0.240 |
Why?
| | HMGB1 Protein | 3 | 2015 | 51 | 0.230 |
Why?
| | Yersinia pestis | 1 | 2006 | 45 | 0.230 |
Why?
| | Bacteria | 2 | 2011 | 766 | 0.210 |
Why?
| | Adenine | 3 | 2008 | 338 | 0.210 |
Why?
| | Endopeptidases | 2 | 2022 | 80 | 0.210 |
Why?
| | Nucleoproteins | 2 | 1994 | 37 | 0.200 |
Why?
| | Porifera | 2 | 2014 | 8 | 0.200 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2023 | 18 | 0.200 |
Why?
| | Gene Silencing | 2 | 2023 | 200 | 0.200 |
Why?
| | Virulence | 3 | 2018 | 287 | 0.190 |
Why?
| | RNA, Ribosomal, 5S | 3 | 1990 | 5 | 0.180 |
Why?
| | Rhenium | 1 | 2001 | 3 | 0.180 |
Why?
| | Pantoea | 1 | 2001 | 2 | 0.180 |
Why?
| | Capsid | 1 | 2022 | 94 | 0.170 |
Why?
| | Recombinant Proteins | 7 | 2008 | 1361 | 0.170 |
Why?
| | Bacteriophage lambda | 1 | 2022 | 89 | 0.170 |
Why?
| | Capsid Proteins | 1 | 2022 | 94 | 0.170 |
Why?
| | Virus Assembly | 1 | 2022 | 81 | 0.170 |
Why?
| | HMGB Proteins | 3 | 2008 | 16 | 0.170 |
Why?
| | Adenosine | 1 | 2003 | 255 | 0.170 |
Why?
| | RNA, Ribosomal | 3 | 1990 | 168 | 0.170 |
Why?
| | Rhodobacter sphaeroides | 1 | 2000 | 7 | 0.160 |
Why?
| | Mammals | 1 | 2022 | 287 | 0.160 |
Why?
| | Cyclin A | 2 | 2011 | 17 | 0.160 |
Why?
| | Structure-Activity Relationship | 4 | 2013 | 561 | 0.160 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2013 | 144 | 0.160 |
Why?
| | Ligands | 2 | 2018 | 676 | 0.160 |
Why?
| | DNA, Single-Stranded | 2 | 1991 | 117 | 0.160 |
Why?
| | Centrosome | 2 | 2011 | 67 | 0.150 |
Why?
| | Archaeal Proteins | 1 | 2000 | 49 | 0.150 |
Why?
| | Burkholderia | 2 | 2009 | 10 | 0.150 |
Why?
| | Xenopus Proteins | 2 | 2012 | 33 | 0.140 |
Why?
| | DNA Repair | 2 | 1991 | 254 | 0.140 |
Why?
| | Oligodeoxyribonucleotides | 3 | 2016 | 141 | 0.140 |
Why?
| | Sea Urchins | 2 | 2016 | 6 | 0.140 |
Why?
| | Entropy | 2 | 2011 | 44 | 0.130 |
Why?
| | Humans | 26 | 2019 | 145625 | 0.130 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2012 | 88 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2016 | 369 | 0.130 |
Why?
| | Gene Deletion | 3 | 2013 | 384 | 0.130 |
Why?
| | Pseudomonas Infections | 2 | 2011 | 229 | 0.130 |
Why?
| | Nuclear Proteins | 3 | 2012 | 739 | 0.120 |
Why?
| | Operon | 2 | 2007 | 67 | 0.120 |
Why?
| | Xenopus | 3 | 2010 | 85 | 0.120 |
Why?
| | Serum Response Factor | 1 | 2016 | 33 | 0.120 |
Why?
| | Deuterium | 2 | 2011 | 101 | 0.120 |
Why?
| | DNA Primers | 3 | 2012 | 487 | 0.120 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2006 | 124 | 0.110 |
Why?
| | Gene Expression Regulation | 4 | 2016 | 2591 | 0.110 |
Why?
| | Models, Biological | 2 | 2013 | 1758 | 0.110 |
Why?
| | Polymerase Chain Reaction | 2 | 1999 | 1030 | 0.110 |
Why?
| | Rhodobacteraceae | 1 | 2014 | 1 | 0.110 |
Why?
| | Hemagglutinins, Viral | 1 | 1994 | 8 | 0.110 |
Why?
| | Protein Interaction Mapping | 2 | 2012 | 105 | 0.110 |
Why?
| | Sumoylation | 1 | 2014 | 17 | 0.110 |
Why?
| | SUMO-1 Protein | 1 | 2014 | 18 | 0.110 |
Why?
| | PTEN Phosphohydrolase | 1 | 2016 | 166 | 0.110 |
Why?
| | Escherichia coli | 4 | 2008 | 831 | 0.100 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2017 | 257 | 0.100 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 1994 | 55 | 0.100 |
Why?
| | Genes, Retinoblastoma | 1 | 1994 | 9 | 0.100 |
Why?
| | Mutant Proteins | 2 | 2013 | 103 | 0.100 |
Why?
| | CREB-Binding Protein | 1 | 2014 | 34 | 0.100 |
Why?
| | Symbiosis | 1 | 2014 | 71 | 0.100 |
Why?
| | Base Composition | 3 | 1990 | 81 | 0.100 |
Why?
| | Chromatography, Liquid | 3 | 2011 | 452 | 0.100 |
Why?
| | Thermodynamics | 4 | 2012 | 418 | 0.100 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 271 | 0.100 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 28 | 0.100 |
Why?
| | Phospholipases | 1 | 2013 | 14 | 0.100 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 1994 | 100 | 0.100 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2013 | 23 | 0.100 |
Why?
| | Neurodevelopmental Disorders | 1 | 2016 | 234 | 0.100 |
Why?
| | Glycolipids | 1 | 2013 | 53 | 0.100 |
Why?
| | Thymine | 2 | 2008 | 16 | 0.090 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2014 | 218 | 0.090 |
Why?
| | Roseobacter | 1 | 2012 | 1 | 0.090 |
Why?
| | Locomotion | 1 | 2013 | 102 | 0.090 |
Why?
| | Hydrolysis | 1 | 2013 | 195 | 0.090 |
Why?
| | Amino Acid Substitution | 3 | 2012 | 295 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2016 | 507 | 0.090 |
Why?
| | Tandem Mass Spectrometry | 3 | 2011 | 574 | 0.090 |
Why?
| | DNA, Bacterial | 2 | 2011 | 319 | 0.090 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2012 | 4 | 0.090 |
Why?
| | Cholesterol, HDL | 1 | 2013 | 201 | 0.090 |
Why?
| | Fimbriae Proteins | 2 | 2013 | 25 | 0.090 |
Why?
| | Protein Kinase C-alpha | 1 | 2012 | 37 | 0.090 |
Why?
| | Dimerization | 3 | 2006 | 174 | 0.090 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2012 | 56 | 0.090 |
Why?
| | Crystallography | 2 | 2006 | 26 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2016 | 899 | 0.090 |
Why?
| | Response Elements | 2 | 2011 | 84 | 0.090 |
Why?
| | Xenopus laevis | 2 | 2011 | 101 | 0.090 |
Why?
| | Enzyme Activation | 1 | 2013 | 758 | 0.080 |
Why?
| | Ultraviolet Rays | 2 | 1991 | 376 | 0.080 |
Why?
| | Staining and Labeling | 1 | 2012 | 148 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 5 | 2007 | 627 | 0.080 |
Why?
| | Circular Dichroism | 1 | 2011 | 149 | 0.080 |
Why?
| | Hydrogen Bonding | 3 | 2000 | 170 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2012 | 165 | 0.080 |
Why?
| | Markov Chains | 1 | 2011 | 128 | 0.080 |
Why?
| | Carbodiimides | 1 | 2011 | 2 | 0.080 |
Why?
| | Genetic Association Studies | 1 | 2013 | 376 | 0.080 |
Why?
| | Catalytic Domain | 2 | 2003 | 234 | 0.080 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.080 |
Why?
| | Cyclin E | 1 | 2011 | 23 | 0.080 |
Why?
| | Protein Stability | 1 | 2011 | 175 | 0.080 |
Why?
| | Cell Survival | 2 | 1991 | 1102 | 0.080 |
Why?
| | Genes | 2 | 1990 | 215 | 0.080 |
Why?
| | Metalloproteins | 1 | 1990 | 6 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2016 | 884 | 0.080 |
Why?
| | Hydroxides | 5 | 1990 | 28 | 0.080 |
Why?
| | DNA, Ribosomal | 1 | 1990 | 83 | 0.080 |
Why?
| | Models, Genetic | 2 | 1994 | 537 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2016 | 843 | 0.080 |
Why?
| | Antibodies, Viral | 1 | 1994 | 683 | 0.080 |
Why?
| | Alleles | 1 | 2013 | 900 | 0.080 |
Why?
| | Chemoreceptor Cells | 1 | 2010 | 50 | 0.080 |
Why?
| | Myocytes, Cardiac | 1 | 2014 | 542 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 485 | 0.080 |
Why?
| | Biofilms | 1 | 2012 | 288 | 0.070 |
Why?
| | Bayes Theorem | 1 | 2011 | 424 | 0.070 |
Why?
| | Nasal Mucosa | 1 | 2010 | 112 | 0.070 |
Why?
| | Light | 1 | 1991 | 400 | 0.070 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2016 | 180 | 0.070 |
Why?
| | Burkholderia mallei | 1 | 2008 | 7 | 0.070 |
Why?
| | Peptide Fragments | 2 | 2007 | 693 | 0.070 |
Why?
| | Amino Acid Motifs | 2 | 2011 | 217 | 0.070 |
Why?
| | Genotype | 1 | 2013 | 1866 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2010 | 232 | 0.070 |
Why?
| | Pseudomonas | 1 | 2007 | 30 | 0.070 |
Why?
| | Static Electricity | 3 | 2004 | 113 | 0.060 |
Why?
| | Taste | 1 | 2010 | 237 | 0.060 |
Why?
| | Fimbriae, Bacterial | 1 | 2007 | 36 | 0.060 |
Why?
| | Free Radicals | 5 | 1990 | 104 | 0.060 |
Why?
| | Vaccines, Synthetic | 1 | 2007 | 138 | 0.060 |
Why?
| | Cell Cycle | 1 | 2010 | 595 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 1994 | 927 | 0.060 |
Why?
| | Cricetinae | 3 | 2011 | 295 | 0.060 |
Why?
| | Hydroxyl Radical | 4 | 1990 | 86 | 0.060 |
Why?
| | Proteins | 2 | 1995 | 1021 | 0.060 |
Why?
| | Acetylation | 3 | 2014 | 262 | 0.060 |
Why?
| | Alanine | 1 | 2006 | 171 | 0.060 |
Why?
| | Receptors, Cell Surface | 1 | 2007 | 371 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2228 | 0.060 |
Why?
| | Molecular Structure | 2 | 2007 | 483 | 0.050 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 3 | 2009 | 348 | 0.050 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2012 | 79 | 0.050 |
Why?
| | Kinetics | 3 | 2004 | 1553 | 0.050 |
Why?
| | Acyl Carrier Protein | 1 | 2004 | 8 | 0.050 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 184 | 0.050 |
Why?
| | Phosphorylation | 3 | 2013 | 1717 | 0.050 |
Why?
| | Nucleic Acid Heteroduplexes | 2 | 1997 | 9 | 0.050 |
Why?
| | Crossing Over, Genetic | 1 | 2003 | 7 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2005 | 319 | 0.050 |
Why?
| | Chlorine | 1 | 2003 | 59 | 0.050 |
Why?
| | Amino Acids | 2 | 2005 | 513 | 0.050 |
Why?
| | Colorado | 1 | 2013 | 4588 | 0.050 |
Why?
| | Serogroup | 1 | 2022 | 46 | 0.050 |
Why?
| | HMGB2 Protein | 1 | 2002 | 4 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2005 | 443 | 0.040 |
Why?
| | DNA Mutational Analysis | 2 | 2016 | 409 | 0.040 |
Why?
| | Models, Chemical | 1 | 2003 | 252 | 0.040 |
Why?
| | Proteolysis | 1 | 2022 | 174 | 0.040 |
Why?
| | Inflammation | 1 | 2013 | 2915 | 0.040 |
Why?
| | CHO Cells | 2 | 2011 | 167 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2004 | 405 | 0.040 |
Why?
| | DNA-Cytosine Methylases | 1 | 2000 | 3 | 0.040 |
Why?
| | Protein Folding | 1 | 2022 | 281 | 0.040 |
Why?
| | Cricetulus | 2 | 2011 | 115 | 0.040 |
Why?
| | HEK293 Cells | 2 | 2014 | 746 | 0.040 |
Why?
| | S-Adenosylmethionine | 1 | 2000 | 58 | 0.040 |
Why?
| | Nitrogen Isotopes | 1 | 2000 | 69 | 0.040 |
Why?
| | Lung Neoplasms | 1 | 1994 | 2674 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 210 | 0.040 |
Why?
| | Disulfides | 2 | 1997 | 93 | 0.040 |
Why?
| | Carbon Isotopes | 1 | 2000 | 143 | 0.040 |
Why?
| | Nucleotides | 1 | 2000 | 128 | 0.040 |
Why?
| | Catalysis | 1 | 2000 | 304 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2016 | 2533 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2009 | 1244 | 0.040 |
Why?
| | Mice | 6 | 2016 | 18266 | 0.040 |
Why?
| | Chromatography, Ion Exchange | 1 | 1999 | 57 | 0.040 |
Why?
| | Cell Line | 3 | 2010 | 2809 | 0.040 |
Why?
| | COS Cells | 2 | 2009 | 173 | 0.030 |
Why?
| | Chromosomes | 1 | 1999 | 105 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2009 | 1935 | 0.030 |
Why?
| | Cytochromes c | 1 | 1998 | 53 | 0.030 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2131 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1999 | 526 | 0.030 |
Why?
| | Electrophoresis | 1 | 1997 | 31 | 0.030 |
Why?
| | Fungal Proteins | 1 | 1998 | 137 | 0.030 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 1998 | 130 | 0.030 |
Why?
| | Muscidae | 1 | 1996 | 1 | 0.030 |
Why?
| | Rats | 2 | 2016 | 5574 | 0.030 |
Why?
| | DNA Nucleotidyltransferases | 1 | 1996 | 11 | 0.030 |
Why?
| | Methionine | 1 | 1997 | 160 | 0.030 |
Why?
| | Water | 1 | 2000 | 451 | 0.030 |
Why?
| | Ataxia | 1 | 2016 | 69 | 0.030 |
Why?
| | Fluorescence | 2 | 2010 | 160 | 0.030 |
Why?
| | Strabismus | 1 | 2016 | 71 | 0.030 |
Why?
| | Transfection | 2 | 2012 | 914 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2010 | 326 | 0.030 |
Why?
| | Protein Kinases | 1 | 1998 | 311 | 0.030 |
Why?
| | Syndrome | 1 | 2016 | 377 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 1996 | 125 | 0.030 |
Why?
| | United Kingdom | 1 | 2016 | 376 | 0.030 |
Why?
| | Canada | 1 | 2016 | 430 | 0.030 |
Why?
| | Fushi Tarazu Transcription Factors | 1 | 1995 | 5 | 0.030 |
Why?
| | Face | 1 | 2016 | 177 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2016 | 178 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1995 | 185 | 0.030 |
Why?
| | Gene Order | 1 | 2014 | 29 | 0.030 |
Why?
| | Antibody Formation | 1 | 2016 | 290 | 0.030 |
Why?
| | Age of Onset | 1 | 2016 | 557 | 0.030 |
Why?
| | Binding Sites, Antibody | 1 | 1994 | 41 | 0.030 |
Why?
| | Antigen-Antibody Reactions | 1 | 1994 | 50 | 0.030 |
Why?
| | Adjuvants, Immunologic | 1 | 2016 | 243 | 0.030 |
Why?
| | Biocatalysis | 1 | 2014 | 68 | 0.030 |
Why?
| | Neutrons | 1 | 1994 | 10 | 0.030 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1994 | 33 | 0.030 |
Why?
| | Tyrosine | 1 | 1995 | 217 | 0.030 |
Why?
| | Plasmids | 2 | 2004 | 372 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 1997 | 728 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 3 | 2004 | 662 | 0.030 |
Why?
| | Molecular Weight | 3 | 2005 | 295 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 1994 | 120 | 0.030 |
Why?
| | Inverted Repeat Sequences | 1 | 2013 | 18 | 0.020 |
Why?
| | Developmental Disabilities | 1 | 2016 | 280 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 1997 | 1075 | 0.020 |
Why?
| | Protein Biosynthesis | 2 | 2014 | 447 | 0.020 |
Why?
| | Transcription Factor TFIIIA | 2 | 1990 | 5 | 0.020 |
Why?
| | Genetic Loci | 1 | 2014 | 272 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2016 | 449 | 0.020 |
Why?
| | Methods | 2 | 1990 | 68 | 0.020 |
Why?
| | Conserved Sequence | 2 | 2007 | 242 | 0.020 |
Why?
| | Histone Deacetylases | 1 | 2014 | 208 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2012 | 27 | 0.020 |
Why?
| | Drosophila | 1 | 2014 | 168 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 845 | 0.020 |
Why?
| | HeLa Cells | 1 | 2014 | 635 | 0.020 |
Why?
| | Epitopes | 1 | 1994 | 479 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2012 | 128 | 0.020 |
Why?
| | Lysine | 1 | 2014 | 302 | 0.020 |
Why?
| | Point Mutation | 1 | 2012 | 232 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2014 | 887 | 0.020 |
Why?
| | Netropsin | 1 | 1991 | 1 | 0.020 |
Why?
| | Serine | 1 | 2012 | 142 | 0.020 |
Why?
| | Temperature | 2 | 2004 | 633 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 1995 | 525 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1991 | 141 | 0.020 |
Why?
| | G1 Phase | 1 | 2011 | 64 | 0.020 |
Why?
| | S Phase | 1 | 2011 | 77 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2011 | 36 | 0.020 |
Why?
| | Molecular Conformation | 1 | 1991 | 141 | 0.020 |
Why?
| | Distamycins | 1 | 1990 | 1 | 0.020 |
Why?
| | Models, Structural | 1 | 1990 | 40 | 0.020 |
Why?
| | Dactinomycin | 1 | 1990 | 24 | 0.020 |
Why?
| | Edetic Acid | 1 | 1990 | 47 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 1990 | 76 | 0.020 |
Why?
| | Heterotrimeric GTP-Binding Proteins | 1 | 2010 | 11 | 0.020 |
Why?
| | Guanine | 1 | 1990 | 85 | 0.020 |
Why?
| | Trigeminal Nerve | 1 | 2010 | 27 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 64 | 0.020 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2010 | 50 | 0.020 |
Why?
| | Burkholderia Infections | 1 | 2009 | 6 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 150 | 0.020 |
Why?
| | Leucine Zippers | 1 | 2009 | 13 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3538 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2009 | 106 | 0.020 |
Why?
| | TRPM Cation Channels | 1 | 2010 | 74 | 0.020 |
Why?
| | Ovary | 1 | 1991 | 235 | 0.020 |
Why?
| | Spermatozoa | 1 | 1989 | 103 | 0.020 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2010 | 121 | 0.020 |
Why?
| | Fibroblasts | 1 | 2014 | 1033 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3121 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2009 | 190 | 0.020 |
Why?
| | Hydroxylation | 1 | 1988 | 47 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 403 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4112 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1979 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2007 | 24 | 0.020 |
Why?
| | Phenazines | 1 | 2007 | 17 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2007 | 157 | 0.020 |
Why?
| | Blotting, Western | 1 | 2010 | 1176 | 0.020 |
Why?
| | Deoxyribonuclease I | 3 | 1995 | 42 | 0.020 |
Why?
| | Zinc | 1 | 1990 | 310 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 1994 | 1511 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2007 | 125 | 0.020 |
Why?
| | DNA Footprinting | 2 | 1996 | 33 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1709 | 0.010 |
Why?
| | Ultracentrifugation | 1 | 2005 | 49 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 2005 | 131 | 0.010 |
Why?
| | Immunization | 1 | 2007 | 375 | 0.010 |
Why?
| | Aurora Kinase B | 1 | 2005 | 10 | 0.010 |
Why?
| | Aurora Kinases | 1 | 2005 | 25 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2016 | 6449 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 771 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2004 | 205 | 0.010 |
Why?
| | Zinc Fingers | 1 | 2004 | 50 | 0.010 |
Why?
| | Glutathione Transferase | 1 | 2004 | 92 | 0.010 |
Why?
| | Estrogen Receptor beta | 1 | 2004 | 40 | 0.010 |
Why?
| | Male | 4 | 2016 | 73014 | 0.010 |
Why?
| | Calcium | 1 | 2010 | 1181 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2005 | 588 | 0.010 |
Why?
| | Calorimetry | 1 | 2003 | 69 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 1994 | 6021 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 2078 | 0.010 |
Why?
| | Estrogen Receptor alpha | 1 | 2004 | 154 | 0.010 |
Why?
| | Infant | 1 | 2016 | 10093 | 0.010 |
Why?
| | Peptides | 1 | 2008 | 991 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2018 | 0.010 |
Why?
| | Female | 4 | 2016 | 79080 | 0.010 |
Why?
| | Sex-Determining Region Y Protein | 1 | 1998 | 7 | 0.010 |
Why?
| | Hydro-Lyases | 1 | 1998 | 7 | 0.010 |
Why?
| | Precipitin Tests | 1 | 1998 | 90 | 0.010 |
Why?
| | Lymphoid Enhancer-Binding Factor 1 | 1 | 1998 | 6 | 0.010 |
Why?
| | Cytochrome c Group | 1 | 1998 | 43 | 0.010 |
Why?
| | Acetyltransferases | 1 | 1998 | 27 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1998 | 73 | 0.010 |
Why?
| | Yeasts | 1 | 1998 | 54 | 0.010 |
Why?
| | DNA Restriction Enzymes | 2 | 1988 | 46 | 0.010 |
Why?
| | Histone Acetyltransferases | 1 | 1998 | 57 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 22451 | 0.010 |
Why?
| | Manganese Compounds | 1 | 1996 | 4 | 0.010 |
Why?
| | Transposases | 1 | 1996 | 18 | 0.010 |
Why?
| | Child | 1 | 2016 | 22638 | 0.010 |
Why?
| | Chlorides | 1 | 1996 | 138 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1995 | 207 | 0.010 |
Why?
| | Oligonucleotides | 1 | 1995 | 154 | 0.010 |
Why?
| | Solutions | 1 | 1994 | 159 | 0.010 |
Why?
| | RNA, Messenger | 2 | 1993 | 2783 | 0.010 |
Why?
| | Phylogeny | 1 | 1996 | 921 | 0.010 |
Why?
| | Software | 1 | 1998 | 673 | 0.010 |
Why?
| | Larva | 1 | 1993 | 242 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 1993 | 505 | 0.010 |
Why?
| | Diethyl Pyrocarbonate | 1 | 1990 | 3 | 0.010 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1990 | 26 | 0.010 |
Why?
| | Endonucleases | 1 | 1990 | 34 | 0.010 |
Why?
| | Magnesium | 1 | 1990 | 155 | 0.000 |
Why?
| | Copper | 1 | 1990 | 122 | 0.000 |
Why?
| | Computer Simulation | 1 | 1994 | 1014 | 0.000 |
Why?
| | Purines | 1 | 1990 | 188 | 0.000 |
Why?
| | Nucleotide Mapping | 1 | 1988 | 3 | 0.000 |
Why?
| | Iron | 1 | 1990 | 359 | 0.000 |
Why?
| | Chromosome Deletion | 1 | 1988 | 126 | 0.000 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1987 | 27 | 0.000 |
Why?
| | Oocytes | 1 | 1988 | 186 | 0.000 |
Why?
| | Indicators and Reagents | 1 | 1987 | 105 | 0.000 |
Why?
| | Viral Proteins | 1 | 1987 | 350 | 0.000 |
Why?
|
|
Churchill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|